Skip to content
10-Q

Quarterly Report

Quoin Pharmaceuticals, Ltd. QNRX

0001410578-25-001613

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$6.28M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$3.44M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.67M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.62M
Stockholders Equity Q2 2025 · Jun 30, 2025 $2.55M
Stockholders Equity Q2 2025 · Mar 31, 2025 $5.93M
Stockholders Equity Q2 2025 · Dec 31, 2024 $9.2M
Stockholders Equity Q2 2025 · Jun 30, 2024 $7.48M
Stockholders Equity Q2 2025 · Mar 31, 2024 $9.13M
Stockholders Equity Q2 2025 · Dec 31, 2023 $5.66M
Current Liabilities Q2 2025 · Jun 30, 2025 $4.34M
Current Liabilities Q2 2025 · Dec 31, 2024 $4.18M
Total Liabilities Q2 2025 · Jun 30, 2025 $6.36M
Total Liabilities Q2 2025 · Dec 31, 2024 $6.5M
Current Assets Q2 2025 · Jun 30, 2025 $8.48M
Current Assets Q2 2025 · Dec 31, 2024 $14.93M
Total Assets Q2 2025 · Jun 30, 2025 $8.91M
Total Assets Q2 2025 · Dec 31, 2024 $15.71M
Sga Expense Q2 2025 · Jun 30, 2025 $1.74M
Sga Expense Q2 2025 · Jun 30, 2025 $3.33M
Sga Expense restated Q2 2025 · Jun 30, 2024 $1.55M
Sga Expense restated Q2 2025 · Jun 30, 2024 $3.12M
Rd Expense Q2 2025 · Jun 30, 2025 $2.05M
Rd Expense Q2 2025 · Jun 30, 2025 $4.42M
Rd Expense restated Q2 2025 · Jun 30, 2024 $587.5K
Rd Expense restated Q2 2025 · Jun 30, 2024 $1.47M
Net Income Q2 2025 · Jun 30, 2025 −$3.7M
Net Income Q2 2025 · Jun 30, 2025 −$7.51M
Net Income Q2 2025 · Mar 31, 2025 −$3.81M
Net Income Q2 2025 · Jun 30, 2024 −$1.97M
Net Income Q2 2025 · Jun 30, 2024 −$4.3M
Net Income Q2 2025 · Mar 31, 2024 −$2.33M